Scientists approach bacteria behind streptococcal phonographies and scarlet fever
Scientists studying bacteria from scarlet fever, chronic sore throat and heart disease say that they are getting closer to developing a vaccine for hundreds of infections.
In a study published in the journal of Nature Bateson, Great Britain, and Australia, scientists said that the detailed difference between the 22 countries of the Group A strep A bacteria striprreakeakkak strainukal from, but they are many types of different types of Molecular tarjarrukalum kantettiyita And tundra, offers a chance to develop what the vaccine.
Streptococcal infection is one of the main causes of death from this type of disease in the world. It is estimated that more than half a million deaths each year.
From streptococcal forensicis to scarlet fever – can cause a variety of infections – constant fear in many parts of the world – a rheumatic heart disease – affecting people in Australia, including adivasis.
There is no effective vaccine for Streptococcus Efforts to develop one's personnel through streptococcal pressure to develop more than one. This means that it is very difficult to develop a vaccine that is effective.
In research, Great Britain's Wellcome Sangre Institute, Cambridge University, Doorate Institute of Australia, Queensland University, and more than 2,000 samples from 22 countries, including African countries, Australian audiences.
"Using all the information we collect, we have shortened the genes that are common to almost all types of stray acres around the world," said Mark Davis of Wellington Sangger, Doherty College, and colleagues' colleagues. "It's a big step for finding out what works like a global vaccine."